. 2017; 34(1): 27-33 | DOI: 10.4274/tjh.2016.0005 | |||
Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative NeoplasmsNur Soyer1, İbrahim C Haznedaroğlu2, Melda Cömert1, Demet Çekdemir3, Mehmet Yılmaz4, Ali Ünal5, Gülsüm Çağlıyan6, Oktay Bilgir6, Osman İlhan7, Füsun Özdemirkıran8, Emin Kaya9, Fahri Şahin1, Filiz Vural1, Güray Saydam11Ege University Faculty of Medicine, Department of Hematology, İzmir, Turkey2Hacettepe University Faculty of Medicine, Department of Hematology, Ankara, Turkey 3Sakarya University Training and Research Hospital, Clinic of Hematology, Sakarya, Turkey 4Gaziantep University Faculty of Medicine, Department of Hematology, Gaziantep, Turkey 5Erciyes University Faculty of Medicine, Department of Hematology, Kayseri, Turkey 6İzmir Bozyaka Training and Research Hospital, Clinic of Hematology, İzmir, Turkey 7Ankara University Faculty of Medicine Hospital, Department of Hematology, Ankara, Turkey 8İzmir Atatürk Training and Research Hospital, Clinic of Hematology, İzmir, Turkey 9İnönü University Faculty of Medicine Hospital, Department of Hematology, Malatya, Turkey Objective: Chronic myeloproliferative neoplasms (CMPNs) that include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) are Philadelphia-negative malignancies characterized by a clonal proliferation of one or several lineages. The aim of this report was to determine the demographic features, disease characteristics, treatment strategies, and survival rates of patients with CMPNs in Turkey. Kronik Miyeloproliferatif Neoplazi Tanılı Türk Hastaların Geriye Dönük ve Çok Merkezli AnaliziNur Soyer1, İbrahim C Haznedaroğlu2, Melda Cömert1, Demet Çekdemir3, Mehmet Yılmaz4, Ali Ünal5, Gülsüm Çağlıyan6, Oktay Bilgir6, Osman İlhan7, Füsun Özdemirkıran8, Emin Kaya9, Fahri Şahin1, Filiz Vural1, Güray Saydam11Ege University Faculty of Medicine, Department of Hematology, İzmir, Turkey2Hacettepe University Faculty of Medicine, Department of Hematology, Ankara, Turkey 3Sakarya University Training and Research Hospital, Clinic of Hematology, Sakarya, Turkey 4Gaziantep University Faculty of Medicine, Department of Hematology, Gaziantep, Turkey 5Erciyes University Faculty of Medicine, Department of Hematology, Kayseri, Turkey 6İzmir Bozyaka Training and Research Hospital, Clinic of Hematology, İzmir, Turkey 7Ankara University Faculty of Medicine Hospital, Department of Hematology, Ankara, Turkey 8İzmir Atatürk Training and Research Hospital, Clinic of Hematology, İzmir, Turkey 9İnönü University Faculty of Medicine Hospital, Department of Hematology, Malatya, Turkey Amaç: Polisitemia vera (PV), esansiyel trombositemi (ET) ve primer miyelofibrozu (PMF) içeren kronik miyeloproliferatif neoplaziler (KMPN), bir ya da birden fazla serinin klonal proliferasyonu ile karakterize Philadelphia kromozomu negatif olan malignitelerdir. Bu çalışmanın amacı, Türkiye’de KMPN’li hastaların demografik özellikleri, hastalık karakteristikleri, tedavi stratejileri ve yaşam oranlarını belirlemektir. Nur Soyer, İbrahim C Haznedaroğlu, Melda Cömert, Demet Çekdemir, Mehmet Yılmaz, Ali Ünal, Gülsüm Çağlıyan, Oktay Bilgir, Osman İlhan, Füsun Özdemirkıran, Emin Kaya, Fahri Şahin, Filiz Vural, Güray Saydam. Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms. . 2017; 34(1): 27-33 Corresponding Author: Nur Soyer, Türkiye |
|